APA (7th ed.) Citation

Piazza, G., Spyropoulos, A. C., Hsia, J., Goldin, M., Towner, W. J., Go, A. S., . . . Bonaca, M. P. (2023). Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial. Circulation (New York, N.Y.), 147(25), 1891. https://doi.org/10.1161/CIRCULATIONAHA.123.063901

Chicago Style (17th ed.) Citation

Piazza, Gregory, et al. "Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial." Circulation (New York, N.Y.) 147, no. 25 (2023): 1891. https://doi.org/10.1161/CIRCULATIONAHA.123.063901.

MLA (9th ed.) Citation

Piazza, Gregory, et al. "Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial." Circulation (New York, N.Y.), vol. 147, no. 25, 2023, p. 1891, https://doi.org/10.1161/CIRCULATIONAHA.123.063901.